AZD-9567

Research use only, not for human use.

AZD-9567 (AZD9567) is a potent, selective, non-steroidal and orally available selective glucocorticoid receptor modulator (SGRM) for treatment of rheumatoid arthritis.

AZD-9567 (AZD9567) is a potent, selective, non-steroidal and orally available selective glucocorticoid receptor modulator (SGRM) for treatment of rheumatoid arthritis.Rheumatoid Arthritis Phase 2 Clinical.

——

Mizacorat (15 mg/kg/day, Oral gavage daily for 8 days) treatment shows excellent in vivo efficacy in a rat model of joint inflammation. Animal Model:Antigen-induced joint inflammation model in female Lewis rats (175-200 g), sensitized by an intra-articular injection of 5 μg of SCW.Dosage:15 mg/kg/day.Administration:Oral gavage daily for 8 days.Result:Inhibited ankle swelling in the rat SCW model.

AZD9567

Endocrinology/Hormones

GR

GR

Inflammation/Immunology

Rheumatoid Arthritis

1893415-00-3

494.533

C27H28F2N4O3

>98% (HPLC)

10 mM in DMSO

CC(F)(F)C(N[C@@H](C(C)C)[C@H](OC1=CC2=C(N(C(C=C3)=CN(C)C3=O)N=C2)C=C1)C4=CC=CC=C4)=O

2,2-Difluoro-N-[(1R,2S)-3-methyl-1-[[1-(1-methyl-6-oxo-1,6-dihydropyridin-3-yl)-1H-indazol-5-yl]oxy]-1-phenylbutan-2-yl]propanamide

(-20℃)

With Ice Pack

≥ 2 years